Therapeutic alliance predicts symptomatic improvement session by session.

Therapeutic alliance predicts symptomatic improvement session by session.

The therapeutic alliance has been found to predict psychotherapy outcome in numerous studies. However, critics maintain that the therapeutic alliance is a by-product of prior symptomatic improvements. Moreover, almost all alliance research to date has used differences between patients in alliance as predictor of outcome, and results of such analyses do not necessarily mean that improving the al...

Session 8: Therapeutic antibodies: Infection

Human endogenous retroviral family W (HERV-W) RNA in circulating virion particles (Multiple Sclerosis associated RetroViral element, MSRV) is associated with the evolution and prognosis of Multiple Sclerosis (MS). HERV-W encodes an envelope protein (ENV) that is a potent agonist for Toll-Like Receptor 4 (TLR4) on antigen-presenting cells. It activates a pro-inflammatory and autoimmune cascade, ...

Session 9: Therapeutic antibodies: Cancer

s not provided.

Session 3 : Therapeutic Applications II

To date, the most difficult challenge to antibodybased therapy for a variety of diseases, particularly for cancer, is the balance of robust efficacy and minimal side effects on normal tissues. In the case of cancer intervention, it is highly desirable to have a therapeutics controlling metastasis that accounts for most death of cancer patients and enhancing antitumor immunity that is seriously ...

The Efforts of Therapists in the First Session To Establish a Therapeutic Alliance